Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR

Laloğlu, Esra; Alay, Handan

doi:10.48101/ujms.v127.8211

Makale Tam Makale Uluslararası 2022 Açık erişimli

Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR

Esra Laloğlu, Handan Alay

UPSALA JOURNAL OF MEDICAL SCIENCES Cilt 127 · Sayı 1 · 01.01.2022

DOI ile aç

Özet

Background: Endothelial-specific molecule 1 (endocan) has emerged as an inflammatory biomarker in recent years. The purpose of this study was to investigate the diagnostic value of serum endocan levels in the prediction of COVID-19 disease among patients with a false-negative reverse transcription polymerase change reaction (RT-PCR) test, and also to determine its correlation with the clinical severity of the disease.

Anahtar kelimeler

COVID-19 SARS-CoV-2 Biomarker Endocan reverse transcription polymerase hange reaction

Sürdürülebilir Kalkınma Amaçları

SKA 3: Sağlıklı Bireyler

Atıf için künye

Laloğlu, E., & Alay, H. (2022). Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR. UPSALA JOURNAL OF MEDICAL SCIENCES, 127(1). https://doi.org/10.48101/ujms.v127.8211

BibTeX

@article{laloglu2022-242743,
  author = {Laloğlu, Esra and Alay, Handan},
  title = {Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR},
  journal = {UPSALA JOURNAL OF MEDICAL SCIENCES},
  year = {2022},
  volume = {127},
  number = {1},
  issn = {0300-9734},
  doi = {10.48101/ujms.v127.8211},
  url = {https://akademik.atauni.edu.tr/yayinlar/242743-endocan-as-a-potential-marker-in-diagnosis-and-predicting-disease-severity-in}
}